Armand Glassman to Immunotherapy
This is a "connection" page, showing publications Armand Glassman has written about Immunotherapy.
Connection Strength
0.082
-
Interleukin-2 and lymphokine activated killer cells: promises and cautions. Ann Clin Lab Sci. 1989 Jan-Feb; 19(1):51-5.
Score: 0.069
-
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood. 2005 Jun 15; 105(12):4573-5.
Score: 0.013